Interestingly, there is overlap in site and cisplatin sensitivity of peritoneal mesothelioma and ovarian cancer, a type of cancer for which 18% to 24% of patients will carry a germline mutation in the RAD51D gene [47]. The gene discussed is RAD51D; the disease is peritoneal mesothelioma.